-
The Past Week's Notable Insider Buys: Agree Realty, Avis Budget, Zoetis And More
Sunday, February 28, 2021 - 9:36am | 1027Read More...Insider buying can be an encouraging signal for potential investors, especially when markets face uncertainty. Returning buyers and chief executives were among the insiders making purchases this week. Biotechs, REITs and a car rental leader saw notable insider purchasing of shares. Conventional...
-
Benzinga's Bulls & Bears Of The Week: Amazon, GE, Intel, T-Mobile And More
Sunday, July 1, 2018 - 5:28pm | 897Read More...Benzinga has featured looks at many investor favorite stocks over the past week. Bullish calls included the old-school industrial that was just ousted from the Dow. Bearish calls included a leading semiconductor maker and a supermarket giant. The broader markets saw little progress again this...
-
Biogen And Gilead Sciences Buck Biotech Short Interest Trend
Sunday, June 12, 2016 - 2:35pm | 588Read More...Short interest in many of the leading biotech stocks shrank in the most recent period. Two stocks in particular stood out among the few that bucked the trend in those two weeks. Shares of both of these stocks rose sharply during the two-week period. Short sellers shied away from many of the...
-
Short Interest Surges In Illumina And Vertex Pharmaceuticals
Friday, May 13, 2016 - 1:26pm | 550Read More...Short interest in many of the leading biotech stocks shrank in the most recent period. Two stocks in particular stood out among the few that bucked the trend in those two weeks. Shares of one of those two stocks slumped more than 22 percent during the period. Short sellers shied away from many of...
-
Short Sellers Dump Amgen And Baxalta
Friday, May 13, 2016 - 8:56am | 539Read More...Short interest in many of the leading biotech stocks shrank in the most recent period. Two stocks in particular stood out as leaders of that trend in those two weeks. Shares of one of those two stocks rose while the other slumped during the period. Short sellers moved on only a few of the leading...
-
Short Sellers Dump Vertex, Load Up On Baxalta
Thursday, April 28, 2016 - 8:34am | 588Read More...Short interest in many leading biotech stocks declined in the most recent period. Bucking that trend is a biotech company that soon will be acquired by an overseas peer. Short sellers retreated most sharply from a biotech that some analysts now see as a value stock. Between the March 31 and April...
-
Incyte To Stop A Phase 2 Sub-Study, Shares Lose 10%
Thursday, January 28, 2016 - 12:46pm | 152Read More...Shares of Incyte Corporation (NASDAQ: INCY) fell more than 10 percent on Thursday after the company said it will stop an ongoing Phase 2 sub-study of Ruxolitinib Plus Regorafenib in Patients with Metastatic Colorectal Cancer and High CRP. According to Incyte's press release, the company...
-
More Wild Short Interest Swings In Biotech Stocks
Sunday, December 13, 2015 - 5:52pm | 924Read More...Short interest moves in leading biotech stocks were mixed in the most recent period. However, Illumina, Inc. (NASDAQ: ILMN) and Baxalta Inc (NYSE: BXLT) saw sharp increases in their short interest in late November. Short sellers appeared to lose interest in Juno Lighting LLC (NASDAQ: JUNO) late in...
-
Wild Short Interest Swings For These Three Biotech Stocks
Monday, October 12, 2015 - 3:17pm | 882Read More...Short interest changes in biotech stocks were mixed during the most recent period. Baxalta Inc (NYSE: BXLT) and Juno Therapeutics Inc (NASDAQ: JUNO) saw short interest surges in late September. Short interest in Medivation Inc (NASDAQ: MDVN) plunged during that time. With the ongoing market...
-
3 More Surges In Biotech Short Interest (AMGN, MDVN, PCYC)
Thursday, May 29, 2014 - 8:20am | 826Read More...While Amgen (NASDAQ: AMGN) saw a sizable dip in short interest between the April 30 and May 15 settlement dates, short sellers piled on Medivation (NASDAQ: MDVN) and Pharmacyclics (NASDAQ: PCYC). Among other leading biotechs and emerging pharmaceuticals, gains in the number of their shares sold...
-
Surges In Biotech Short Interest (INCY, PCYC, REGN)
Sunday, May 11, 2014 - 4:35pm | 812Read More...Biotech stocks have proved to be volatile this year, and short sellers piled on Incyte (NASDAQ: INCY) between the April 15 and April 30 settlement dates. Pharmacyclics (NASDAQ: PCYC) and Regeneron Pharmaceuticals (NASDAQ: REGN) also saw double-digit percentage increases in the number of their...
-
Earnings Expectations For The Week Of April 28: Big Oil, Big Pharma And More
Sunday, April 27, 2014 - 11:58am | 854Read More...The earnings crunch continues this week. Among the highlights will be scheduled quarterly reports from Exxon Mobil and Chevron, from Bristol-Myers Squibb and Merck, from Time Warner and Viacom, and also from Twitter. Early Thursday, Exxon Mobil (NYSE: XOM) is expected to say that it had earnings...
-
Short Interest Rises As Biotechs Fall (AMGN, CELG, DNDN)
Thursday, April 10, 2014 - 7:39am | 805Read More...In a period when many biotech stocks were slipping, short sellers moved on many of the leading biotech and emerging pharmaceuticals between the March 14 and March 31 settlement dates. But Amgen (NASDAQ: AMGN), Celgene (NASDAQ: CELG) and Dendreon (NASDAQ: DNDN) were among those that bucked the...
-
Celgene, Pharmacyclics Lead Biotech Short Interest Trend (CELG, MDVN, PCYC)
Wednesday, March 26, 2014 - 7:56am | 806Read More...After largely shying away in the previous period, short sellers found renewed interest in many of the leading biotech and emerging pharmaceutical companies between the February 28 and March 14 settlement dates. But Celgene (NASDAQ: CELG), Medivation (NASDAQ: MDVN) and Pharmacyclics (NASDAQ: PCYC...
-
BioMarin, Medivation Buck Biotech Short Interest Trend (BIIB, BMRN, MDVN)
Wednesday, March 12, 2014 - 10:01am | 808Read More...Short interest in most of the leading biotech and emerging pharmaceutical companies declined between the February 14 and February 28 settlement dates. But Biogen Idec (NASDAQ: BIIB), BioMarin Pharmaceutical (NASDAQ: BMRN) and Medivation (NASDAQ: MDVN) bucked that trend. Short interest in Gilead...
